Approach to the patient with extremely low HDL-cholesterol

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 10, 2012, Pages 3399-3407

  Rader, Daniel J ^a   DeGoma, Emil M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANABOLIC AGENT; ANDROGEN; APOLIPOPROTEIN A1; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; APOLIPOPROTEIN A1 DEFICIENCY; ARTERIAL WALL THICKNESS; ASYMPTOMATIC DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CASE REPORT; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL EVALUATION; COLLEGE STUDENT; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE SEVERITY; DRUG MEGADOSE; ECHOGRAPHY; FOLLOW UP; GENETIC ANALYSIS; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOCHOLESTEROLEMIA; IMMUNOBLOTTING; LECITHIN CHOLESTEROL ACYLTRANSFERASE DEFICIENCY; LIPOPROTEIN DEFICIENCY; LYMPHOMA; MALE; MONOGENIC DISORDER; PARAPROTEINEMIA; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; STEROID THERAPY; TANGIER DISEASE; TONSILLITIS; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; DIAGNOSIS, DIFFERENTIAL; HUMANS; LECITHIN ACYLTRANSFERASE DEFICIENCY; MALE; PARAPROTEINEMIAS; TANGIER DISEASE; YOUNG ADULT;

EID: 84867261181     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2185     Document Type: Review

References (40)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR 1977 High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707-714 (Pubitemid 8110784)
2. Bruckert E 2006 Epidemiology of low HDL-cholesterol: results of studies and surveys. Eur Heart J Suppl 8:F17-F22 (Pubitemid 44453611)
3. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson PW 1994 Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 35:871-882 (Pubitemid 24157238)
4. Degoma EM, Rader DJ 2011 Novel HDL-directed pharmacotherapeutic strategies. Nat Rev Cardiol 8:266-277
5. Langlois MR, Blaton VH 2006 Historical milestones in measurement of HDL-cholesterol: impact on clinical and laboratory practice. Clin Chim Acta 369:168-178
6. Tsai LY, Tsai SM, Lee SC, Liu SF 2005 Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein. Clin Chim Acta 358:192-195
7. Glazer G 1991 Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch Intern Med 151:1925-1933
8. McKenney JM 2008 What is the best place for fibrate therapy in reducing cardiovascular risk? In: Toth PP, Sica DA, eds. Lipid disorders. Oxford, UK: Atlas Publishing
9. Goldberg RB 2006 Impact of thiazolidenediones on serum lipoprotein levels. Curr Atheroscler Rep 8:397-404 (Pubitemid 44340184)
10. Keidar S, Guttmann H, Stam T, Fishman I, Shapira C 2007 High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate. Pharmacoepidemiol Drug Saf 16:1192-1194 (Pubitemid 350120643)
11. Mymin D, Dembinski T, Friesen MH 2009 Iatrogenic severe depression of high-density lipoprotein cholesterol. J Clin Pharmacol 49:865-871
12. Ebcioglu Z, Morgan J, Carey C, Capuzzi D 2003 Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione. Ann Intern Med 139:W80
13. Beghin L, Capps N, Duhal N, Davies J, Staels B, Luc G 1999 Metabolism of apolipoproteins AI and AII in a patient with paradoxical reduction in high-density lipoprotein due to ciprofibrate. Ann Clin Biochem 36:523-525 (Pubitemid 29338575)
14. Garg A, Hosfield EM, Brickner L 2011 Disseminated intravascular large B cell lymphoma with slowly decreasing high-density lipoprotein cholesterol. South Med J 104:53-56
15. Simonelli S, Gianazza E, Mombelli G, Bondioli A, Ferraro G, Penco S, Sirtori CR, Franceschini G, Calabresi L 2012 Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin: cholesterol acyltransferase in non-Hodgkin lymphoma. Arch Intern Med 172:179-181
16. von Eckardstein A 2006 Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis 186:231-239
17. Schaefer EJ, Heaton WH, Wetzel MG, Brewer Jr HB 1982 Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis 2:16-26 (Pubitemid 12111016)
18. Ng DS, Leiter LA, Vezina C, Connelly PW, Hegele RA 1994 Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. J Clin Invest 93:223-229 (Pubitemid 24030840)
19. Schaefer EJ, Santos RD, Asztalos BF 2010 Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol 21:289-297
20. Yokota H, Hashimoto Y, Okubo S, Yumoto M, Mashige F, Kawamura M, Kotani K, Usuki Y, Shimada S, Kitamura K, Nakahara K 2002 Apolipoprotein A-I deficiency with accumulated risk forCHD but no symptoms of CHD. Atherosclerosis 162:399-407 (Pubitemid 34457946)
21. Takata K, Saku K, Ohta T, Takata M, Bai H, Jimi S, Liu R, Sato H, Kajiyama G, Arakawa K 1995 A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease. Arterioscler Thromb Vasc Biol 15:1866-1874
22. Pisciotta L, Miccoli R, Cantafora A, Calabresi L, Tarugi P, Alessandrini P, Bittolo Bon G, Franceschini G, Cortese C, Calandra S, Bertolini S 2003 Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. Atherosclerosis 167:335-345 (Pubitemid 36773533)
23. Franceschini G, Sirtori CR, Capurso 2nd A, Weisgraber KH, Mahley RW 1980 A-I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 66:892-900 (Pubitemid 11233787)
24. Hobbs HH, Rader DJ 1999 ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J Clin Invest 104:1015-1017 (Pubitemid 29536310)
25. Chung S, Timmins JM, Duong M, Degirolamo C, Rong S, Sawyer JK, Singaraja RR, Hayden MR, Maeda N, Rudel LL, Shelness GS, Parks JS 2010 Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism. J Biol Chem 285:12197-12209
26. Sampietro T, Puntoni M, Bigazzi F, Pennato B, Sbrana F, Dal Pino B, Azzarà A, Magagnini E, Perossini P, Cei G, Bacci G 2009 Images in cardiovascular medicine. Tangier disease in severely progressive coronary and peripheral artery disease. Circulation 119:2741-2742
27. Antoine JC, Tommasi M, Boucheron S, Convers P, Laurent B, Michel D 1991 Pathology of roots, spinal cord and brainstem in syringomyelia-like syndrome of Tangier disease. J Neurol Sci 106:179-185
28. Frikke-Schmidt R 2010 Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population. Atherosclerosis 208:305-316
29. Yamamoto S, Tanigawa H, Li X, Komaru Y, Billheimer JT, Rader DJ 2011 Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport. Circulation 124:1382-1390
30. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH 2004 Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869-872 (Pubitemid 39038422)
31. Frikke-Schmidt R, Nordestgaard BG, Stene MC, Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjaerg-Hansen A 2008 Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 299:2524-2532 (Pubitemid 351787208)
32. Norum KR, Gjone E 1967 Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim Biophys Acta 144:698-700
33. Carlson LA 1979 A further case of fish-eye disease. Lancet 2:1376-1377
34. Rousset X, Vaisman B, Amar M, Sethi AA, Remaley AT 2009 Lecithin: cholesterol acyltransferase-from biochemistry to role in cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 16:163-171
35. Strøm EH, Sund S, Reier-Nilsen M, Dørje C, Leren TP 2011 Lecithin: cholesterol acyltransferase (LCAT) deficiency: renal lesions with early graft recurrence. Ultrastruct Pathol 35:139-145
36. Suda T, Akamatsu A, Nakaya Y, Masuda Y, Desaki J 2002 Alterations in erythrocyte membrane lipid and its fragility in a patient with familial lecithin:cholesterol acyltrasferase (LCAT) deficiency. J Med Invest 49:147-155 (Pubitemid 35452971)
37. Calabresi L, Simonelli S, Gomaraschi M, Franceschini G 2012 Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease. Atherosclerosis 222:299-306
38. Calabresi L, Baldassarre D, Castelnuovo S, Conca P, Bocchi L, Candini C, Frigerio B, Amato M, Sirtori CR, Alessandrini P, Arca M, Boscutti G, Cattin L, Gesualdo L, Sampietro T, Vaudo G, Veglia F, Calandra S, Franceschini G 2009 Functional lecithin:cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120:628-635
39. Miarka P, Idzior-Waluoe B, KuŸniewski M, Waluœ-Miarka M, Klupa T, Sułowicz W 2011 Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency. Clin Exp Nephrol 15:424-429
40. Panescu V, Grignon Y, Hestin D, Rostoker G, Frimat L, Renoult E, Gamberoni J, Grignon G, Kessler M 1997 Recurrence of lecithin cholesterol acyltransferase deficiency after kidney transplantation. Nephrol Dial Transplant 12:2430-2432 (Pubitemid 27474636)